118 related articles for article (PubMed ID: 12596249)
1. Troglitazone-induced intracellular oxidative stress in rat hepatoma cells: a flow cytometric assessment.
Narayanan PK; Hart T; Elcock F; Zhang C; Hahn L; McFarland D; Schwartz L; Morgan DG; Bugelski P
Cytometry A; 2003 Mar; 52(1):28-35. PubMed ID: 12596249
[TBL] [Abstract][Full Text] [Related]
2. Troglitazone acts on cellular pH and DNA synthesis through a peroxisome proliferator-activated receptor gamma-independent mechanism in breast cancer-derived cell lines.
Turturro F; Friday E; Fowler R; Surie D; Welbourne T
Clin Cancer Res; 2004 Oct; 10(20):7022-30. PubMed ID: 15501982
[TBL] [Abstract][Full Text] [Related]
3. Critical role of c-Jun N-terminal protein kinase activation in troglitazone-induced apoptosis of human HepG2 hepatoma cells.
Bae MA; Song BJ
Mol Pharmacol; 2003 Feb; 63(2):401-8. PubMed ID: 12527812
[TBL] [Abstract][Full Text] [Related]
4. Troglitazone, but not rosiglitazone, damages mitochondrial DNA and induces mitochondrial dysfunction and cell death in human hepatocytes.
Rachek LI; Yuzefovych LV; Ledoux SP; Julie NL; Wilson GL
Toxicol Appl Pharmacol; 2009 Nov; 240(3):348-54. PubMed ID: 19632256
[TBL] [Abstract][Full Text] [Related]
5. Troglitazone and rosiglitazone induce apoptosis of vascular smooth muscle cells through an extracellular signal-regulated kinase-independent pathway.
Gouni-Berthold I; Berthold HK; Weber AA; Ko Y; Seul C; Vetter H; Sachinidis A
Naunyn Schmiedebergs Arch Pharmacol; 2001 Feb; 363(2):215-21. PubMed ID: 11218074
[TBL] [Abstract][Full Text] [Related]
6. Thiazolidinedione bioactivation: a comparison of the bioactivation potentials of troglitazone, rosiglitazone, and pioglitazone using stable isotope-labeled analogues and liquid chromatography tandem mass spectrometry.
Alvarez-Sanchez R; Montavon F; Hartung T; Pähler A
Chem Res Toxicol; 2006 Aug; 19(8):1106-16. PubMed ID: 16918252
[TBL] [Abstract][Full Text] [Related]
7. Benzo[a]pyrene-induced elevation of GSH level protects against oxidative stress and enhances xenobiotic detoxification in human HepG2 cells.
Lin T; Yang MS
Toxicology; 2007 Jun; 235(1-2):1-10. PubMed ID: 17416446
[TBL] [Abstract][Full Text] [Related]
8. Aroclor 1254 induced cytotoxicity and mitochondrial dysfunction in isolated rat hepatocytes.
Aly HA; Domènech O
Toxicology; 2009 Aug; 262(3):175-83. PubMed ID: 19486918
[TBL] [Abstract][Full Text] [Related]
9. N-Nitrosofenfluramine induces cytotoxicity via mitochondrial dysfunction and oxidative stress in isolated rat hepatocytes.
Nakagawa Y; Suzuki T; Kamimura H; Nagai F
Arch Toxicol; 2005 Jun; 79(6):312-20. PubMed ID: 15696257
[TBL] [Abstract][Full Text] [Related]
10. Peroxisome proliferator-activated receptor gamma ligands induce cell cycle arrest and apoptosis in human renal carcinoma cell lines.
Yang FG; Zhang ZW; Xin DQ; Shi CJ; Wu JP; Guo YL; Guan YF
Acta Pharmacol Sin; 2005 Jun; 26(6):753-61. PubMed ID: 15916743
[TBL] [Abstract][Full Text] [Related]
11. Troglitazone induces a rapid drop of mitochondrial membrane potential in liver HepG2 cells.
Bova MP; Tam D; McMahon G; Mattson MN
Toxicol Lett; 2005 Jan; 155(1):41-50. PubMed ID: 15585358
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of MitoTracker Green and CMXrosamine to measure changes in mitochondrial membrane potentials in living cells and tissues.
Pendergrass W; Wolf N; Poot M
Cytometry A; 2004 Oct; 61(2):162-9. PubMed ID: 15382028
[TBL] [Abstract][Full Text] [Related]
13. Nitric oxide donors prevent while the nitric oxide synthase inhibitor L-NAME increases arachidonic acid plus CYP2E1-dependent toxicity.
Wu D; Cederbaum A
Toxicol Appl Pharmacol; 2006 Oct; 216(2):282-92. PubMed ID: 16938321
[TBL] [Abstract][Full Text] [Related]
14. Troglitazone-induced hepatic mitochondrial proteome expression dynamics in heterozygous Sod2(+/-) mice: two-stage oxidative injury.
Lee YH; Chung MC; Lin Q; Boelsterli UA
Toxicol Appl Pharmacol; 2008 Aug; 231(1):43-51. PubMed ID: 18495193
[TBL] [Abstract][Full Text] [Related]
15. Glutaminolysis and glycolysis regulation by troglitazone in breast cancer cells: Relationship to mitochondrial membrane potential.
Friday E; Oliver R; Welbourne T; Turturro F
J Cell Physiol; 2011 Feb; 226(2):511-9. PubMed ID: 20683912
[TBL] [Abstract][Full Text] [Related]
16. Differentiation of bovine intramuscular and subcutaneous stromal-vascular cells exposed to dexamethasone and troglitazone.
Grant AC; Ortiz-Colón G; Doumit ME; Tempelman RJ; Buskirk DD
J Anim Sci; 2008 Oct; 86(10):2531-8. PubMed ID: 18539836
[TBL] [Abstract][Full Text] [Related]
17. The mitochondrial superoxide/thioredoxin-2/Ask1 signaling pathway is critically involved in troglitazone-induced cell injury to human hepatocytes.
Lim PL; Liu J; Go ML; Boelsterli UA
Toxicol Sci; 2008 Feb; 101(2):341-9. PubMed ID: 17975114
[TBL] [Abstract][Full Text] [Related]
18. Effects of troglitazone on HepG2 viability and mitochondrial function.
Tirmenstein MA; Hu CX; Gales TL; Maleeff BE; Narayanan PK; Kurali E; Hart TK; Thomas HC; Schwartz LW
Toxicol Sci; 2002 Sep; 69(1):131-8. PubMed ID: 12215667
[TBL] [Abstract][Full Text] [Related]
19. Methyl tert-butyl ether (MTBE)-induced cytotoxicity and oxidative stress in isolated rat spermatogenic cells.
Li D; Yin D; Han X
J Appl Toxicol; 2007; 27(1):10-7. PubMed ID: 17177168
[TBL] [Abstract][Full Text] [Related]
20. Chaperone proteins involved in troglitazone-induced toxicity in human hepatoma cell lines.
Maniratanachote R; Minami K; Katoh M; Nakajima M; Yokoi T
Toxicol Sci; 2005 Feb; 83(2):293-302. PubMed ID: 15525695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
